Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What research is currently being conducted on diabetic retinopathy?

April 26, 2017conducted Currently diabetic Research retinopathy

0

Posted

What research is currently being conducted on diabetic retinopathy?

1 Answer

0

Posted

Two new medications are currently being investigated for diabetic retinopathy. LY333531, a protein Kinase C-beta inhibitor (PKC-beta inhibitor) developed by Eli Lilly and Company, is a promising new medication for preventing the progression of diabetic retinopathy. A clinical trial on this medication does not yet have enough data to make a general recommendation to change current management strategies with laser surgery or pars plana vitrectomy. Similarly, Genetech is currently testing Anti-Vascular Endothelial Growth Factors (anti-VEGF) drugs for wet age-related macular degeneration. These anti-VEGF drugs may have future application for the treatment of diabetic retinopathy.